Current Opinion in Infectious Diseases was launched in 1988. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of infectious diseases is divided into 11 sections that are reviewed once a year. Each section is assigned to a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Matteo Bassetti is Head of the Infectious Diseases Clinic of the San Martino-IST University Hospital in Genoa and Full Professor of Infectious Diseases of the University of Genoa, Italy. Dr Bassetti studied at the University of Genoa School of Medicine, Italy and continued his medical education at the Yale University School of Medicine, New Haven, USA with an Infectious Diseases fellowship.
Dr Bassetti is chair of the Critically Ill Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the secretary of the Infectious Diseases Group of the European Organisation for Research and Treatment of Cancer (EORTC). Dr Bassetti is also co-chair of the Intra-abdominal Infections Study Group of the International Society of Chemotherapy (ISC). He is the president of the Italian Society of Anti-infective Therapy (SITA) and member of executive committee for the battle against antimicrobial resistance of the Italian Minister of Health (PNCAR). He is member-elected (2018–2022) of International Council of the Immunocompromised Host Society (ICHS). From 2019 he is member of the council of International Sepsis Forum (ISF). He serves on the editorial board of several journals including Intensive Care Medicine, Nature Scientific Reports, Italian Journal of Medicine (Section Editor), Drugs in Context (Associate editor), Infectious Diseases and Therapy, Journal of Infection and Public Health, Journal of Global Antimicrobial Resistance, Reviews in Medical Microbiology, GMS Infectious Diseases, Journal of Chemotherapy, Infectious Disease, Clinical Microbiology and Antimicrobial Chemotherapy and is a reviewer for several international journals. Author or co-author of 500 papers (H index 58; 12500 citations) published in International peer-review journals and several chapter's book on antibiotic therapy, fungal infections, antimicrobial resistances, infections in immunocompromised patients and critically ill patients.
Michael S. Niederman
Professor Michael S. Niederman is Clinical Director and Associate Chief in the division of Pulmonary and Critical Care Medicine at Weill Cornell Medical Center, New York, and Professor of Clinical Medicine at Weill Cornell Medical College, New York. Prior to this, he was Professor in the Department of Medicine at State University of New York at Stony Brook, and Chairman of the Department of Medicine at Winthrop University Hospital in Mineola, New York for sixteen years. He obtained his medical degree from the Boston University School of Medicine, Massachusetts, and then completed his training in internal medicine at the Northwestern University School of Medicine, Illinois, before undertaking a Pulmonary and Critical Care fellowship at Yale University School of Medicine, Connecticut.
His interests lie in respiratory tract infections, and include mechanisms of airway colonization, the management of community - and hospital-acquired pneumonia, the role of guidelines for pneumonia, and the impact of antibiotic resistance on the management and outcomes of respiratory tract infections. He has published over 400 peer-reviewed or review articles, and has lectured widely both nationally and internationally. Prof. Niederman served as co-chairman of the committees that created the American Thoracic Society 1993 and 2001 guidelines for the treatment of community-acquired pneumonia, as well as the 1996 and 2005 committees that wrote guidelines for the treatment of nosocomial pneumonia. In addition, he was a member of the American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) committee that published guidelines for community-acquired pneumonia in 2007Recently, he was the co-lead author of the 2017 guidelines on nosocomial pneumonia, written on behalf of the European Respiratory Society and the European Society of Intensive Care Medicine. He served for 6 years as a member of the Board of Regents of the American College of Chest Physicians and in 2013 was elected as a Master of the American College of Physicians. He is also Editor-in-Chief of Clinical Pulmonary Medicine, and is an Associate editor of Critical Care and the European Respiratory Review and serves on the editorial boards of Critical Care Medicine, and Intensive Care Medicine. He has previously served on the editorial board of The American Journal of Respiratory and Critical Care Medicine and Chest.